These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8030850)
1. Superiority of antagonic-stress composition versus nicergoline in gerontopsychiatry. Schneider F; Popa R; Mihalas G; Stefanigă P; Mihalas IG; Măties R; Mateescu R Ann N Y Acad Sci; 1994 Jun; 717():332-42. PubMed ID: 8030850 [TBL] [Abstract][Full Text] [Related]
2. Antagonic-stress. A new treatment in gerontopsychiatry and for a healthy productive life. Predescu V; Riga D; Riga S; Turlea J; Bărbat IM; Botezat-Antonescu L Ann N Y Acad Sci; 1994 Jun; 717():315-31. PubMed ID: 8030848 [TBL] [Abstract][Full Text] [Related]
3. Antagonic-stress superiority versus meclofenoxate in gerontopsychiatry (alzheimer type dementia). Popa R; Schneider F; Mihalas G; Stefaniga P; Mihalas IG; Maties R; Mateescu R Arch Gerontol Geriatr; 1994; 19 Suppl 1():197-206. PubMed ID: 18649860 [TBL] [Abstract][Full Text] [Related]
4. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138 [TBL] [Abstract][Full Text] [Related]
5. Prolongevity medicine: Antagonic-Stress drug in distress, geriatrics, and related diseases. II. Clinical review--2003. Riga S; Riga D; Schneider F Ann N Y Acad Sci; 2004 Jun; 1019():401-5. PubMed ID: 15247054 [TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia. Herrmann WM; Stephan K; Gaede K; Apeceche M Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547 [TBL] [Abstract][Full Text] [Related]
7. Ergoloids and ischaemic strokes; efficacy and mechanism of action. Elwan O; Helmy AA; Tamawy ME; Naseer MA; Banhawy IE; Kader AA; Elwan F J Int Med Res; 1995; 23(3):154-66. PubMed ID: 7649339 [TBL] [Abstract][Full Text] [Related]
8. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study. Battaglia A; Bruni G; Ardia A; Sacchetti G J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules]. Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacological analysis of memory disorders of different origins]. Rakhmankulova IKh; Voronina TA Biull Eksp Biol Med; 1989 Jun; 107(6):697-9. PubMed ID: 2571367 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia : Results of a Multicentre, Double-Blind, Placebo-Controlled Study. Nappi G; Bono G; Merlo P; Borromei A; Caltagirone C; Lomeo C; Martucci N; Fabbrini G; Annoni K; Battaglia A Clin Drug Investig; 1997 Jun; 13(6):308-16. PubMed ID: 27519492 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of organic brain syndrome with nicergoline given once a day]. Ladurner G; Erhart P; Erhart C; Scheiber V Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712 [TBL] [Abstract][Full Text] [Related]
13. Nicergoline in the treatment of dizziness in elderly patients. A review. Felisati G; Pignataro O; Di Girolamo A; Bruno E; Alessandrini M; Guidetti G; Monzani D; Beldi AM; Mira E; Benazzo M; Pallestrini E; Caligo G; Casani A; Battaglia A Arch Gerontol Geriatr Suppl; 2004; (9):163-70. PubMed ID: 15207410 [TBL] [Abstract][Full Text] [Related]
14. Shortening of N1 and P3 latencies in event-related potentials observed coincidentally with clinical improvement during nootropic medication in a demented patient: specific effect of nicergoline. Fukuda M; Hiramatsu K; Honda M; Niwa S; Sasaki T; Hata A; Nakagome K; Iwanami A; Honda H; Hayashida S Jpn J Psychiatry Neurol; 1992 Dec; 46(4):919-25. PubMed ID: 1304618 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic potential and possibilities of using of sermion (nicergoline) in neurological practice]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):119-22. PubMed ID: 21434467 [No Abstract] [Full Text] [Related]
16. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation. Wolters M; Hickstein M; Flintermann A; Tewes U; Hahn A Prev Med; 2005 Jul; 41(1):253-9. PubMed ID: 15917019 [TBL] [Abstract][Full Text] [Related]
17. A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis. Bès A; Orgogozo JM; Poncet M; Rancurel G; Weber M; Bertholom N; Calvez R; Stehlé B Eur J Neurol; 1999 May; 6(3):313-22. PubMed ID: 10210912 [TBL] [Abstract][Full Text] [Related]
18. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication]. Meilhac B; Montestruc F; Aubin F; Djian F; Rouffy J Therapie; 1997; 52(3):179-86. PubMed ID: 9366101 [TBL] [Abstract][Full Text] [Related]
19. [Effect of nicergoline on the intellectual performance (author's transl)]. Donoso A; Santander M; Sarce H Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627 [No Abstract] [Full Text] [Related]
20. Nootropic drugs reduce immobility in behavioural despair test in mice. Schmidt J Biomed Biochim Acta; 1984; 43(11):1295-9. PubMed ID: 6442578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]